全球免疫球蛋白市场规模、份额、增长分析，按类型（免疫球蛋白(IVIG) 和皮下免疫球蛋白(SCIG)），按应用（原发性免疫缺陷疾病、自体免疫疾病）- 2024-2031年产业预测

Global Immunoglobulin Market Size, Share, Growth Analysis, By Type(Immunoglobulin (IVIG) and subcutaneous immunoglobulin (SCIG)), By Application(Primary immunodeficiency diseases, autoimmune disorders) - Industry Forecast 2024-2031

出版日期: 2024年04月09日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球免疫球蛋白市场规模为150.5亿美元，预计将从2023年的163.9亿美元成长到2031年的324.2亿美元，在预测期内（2024-2031年）复合年增长率为8.90%。

全球免疫球蛋白市场的大幅成长受到多种因素的推动，包括免疫性疾病发病率的上升、诊断和治疗的进步、支持性监管政策以及医疗保健支出的增加。此外，持续的技术创新和研究投资正在提高免疫球蛋白疗法的有效性和品质。扩展到新兴市场，特别是亚太地区和拉丁美洲，为行业参与者提供了广阔的前景。这些趋势凸显了免疫球蛋白市场的良好前景，强调利害关係人优先考虑创新、扩大产能并采取策略性市场渗透方法以满足对免疫球蛋白疗法不断增长的需求的重要性。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 欧洲其他地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 拉丁美洲其他地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- MEA 的其余部分

竞争格局

前 5 名玩家比较
2021 年关键参与者的市场定位
主要市场参与者所采取的策略
最佳制胜策略
近期市集活动
主要公司市占率（%），2021年

主要公司简介

CSL Behring (Australia)
Grifols (Spain)
Takeda Pharmaceutical Company Limited (Japan)
Octapharma AG (Switzerland)
Kedrion Biopharma (Italy)
Shire (Ireland)
Biotest AG (Germany)
China Biologic Products Holdings, Inc. (China)
Sanquin (Netherlands)
LFB Group (France)
Bio Products Laboratory (UK)
ADMA Biologics, Inc. (USA)
GC Pharma (South Korea)
Bharat Serums and Vaccines Ltd. (India)
Shanghai RAAS Blood Products Co., Ltd. (China)
Grifols Biologicals Inc. (USA)
BPL Plasma, Inc. (USA)
Green Cross Corporation (South Korea)
Beijing Tiantan Biological Products Corporation Limited (China)
Emergent BioSolutions (USA)

简介目录

Product Code: SQMIG35G2149

Global Immunoglobulin Market size was valued at USD 15.05 billion in 2022 and is poised to grow from USD 16.39 billion in 2023 to USD 32.42 billion by 2031, growing at a CAGR of 8.90% during the forecast period (2024-2031).

The substantial growth of the global Immunoglobulin market is propelled by various factors including the rising incidence of immunological disorders, advancements in diagnosis and treatment, supportive regulatory policies, and increased healthcare spending. Furthermore, ongoing technological innovations and research investments are bolstering the effectiveness and quality of Immunoglobulin therapies. Expanding into emerging markets, notably in Asia-Pacific and Latin America, offers promising prospects for industry participants. These trends underscore a favorable outlook for the Immunoglobulin market, emphasizing the importance for stakeholders to prioritize innovation, expand capacities, and adopt strategic market penetration approaches to cater to the growing demand for Immunoglobulin therapies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Immunoglobulin Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Immunoglobulin Market Segmental Analysis

The global immunoglobulin market is segmented by product type, application, and region. Based on type, the market can be segmented into immunoglobulin (IVIG) and subcutaneous immunoglobulin (SCIG). Based on application, the market is segmented into primary immunodeficiency diseases, autoimmune disorders, infectious diseases, hypogammaglobulinemia, neurological disorders, and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Immunoglobulin Market

One significant factor propelling the global Immunoglobulin market is the escalating prevalence of immunological disorders, encompassing primary immunodeficiency diseases, autoimmune disorders, and infectious diseases, for which Immunoglobulins play a pivotal role in treatment. This heightened demand for Immunoglobulin therapies stems from the growing occurrence of such disorders, bolstered by enhanced diagnostic capabilities and heightened awareness. Factors like genetic predisposition, environmental influences, and shifts in lifestyle patterns contribute to the increasing prevalence of immunological disorders worldwide. Furthermore, the market growth is buoyed by advancements in healthcare infrastructure, expanded access to healthcare services, and a rise in healthcare expenditure.

Restraints in the Global Immunoglobulin Market

A significant impediment in the global Immunoglobulin market stems from the elevated expenses associated with Immunoglobulin therapies. The intricate and costly production, purification, and storage processes involved in manufacturing Immunoglobulins contribute to high production costs, consequently influencing the pricing of Immunoglobulin products and rendering them relatively costly for patients and healthcare systems alike. This challenge is particularly pronounced in developing nations with limited healthcare budgets and financial constraints on affordability. Additionally, issues surrounding reimbursement and insurance coverage further exacerbate the financial burden on patients. Vital initiatives aimed at diminishing production costs, fostering market competition, and enhancing accessibility to economical Immunoglobulin therapies are imperative to mitigate this restraint and ensure widespread patient access to these crucial life-saving treatments.

Market Trends of the Global Immunoglobulin Market

One significant trend in the global Immunoglobulin market is the escalating uptake of intravenous immunoglobulin (IVIG) therapy, which entails administering Immunoglobulin intravenously to patients with immunodeficiency disorders, autoimmune diseases, and certain neurological conditions. The surge in demand for IVIG therapy is fueled by its efficacy in treating diverse medical conditions and the widening awareness of its benefits among both healthcare providers and patients. Factors such as advancements in production methods, enhanced product safety, and expanded indications for IVIG therapy are propelling its adoption. Moreover, the rising prevalence of immunological disorders and the growing geriatric population are further driving the increasing demand for Immunoglobulin products and IVIG therapy.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Immunoglobulin Market by Type

Market Overview
Immunoglobulin (IVIG) and subcutaneous immunoglobulin (SCIG)

Global Immunoglobulin Market by Application

Market Overview
Primary immunodeficiency diseases
autoimmune disorders
infectious diseases
hypogammaglobulinemia
neurological disorders
and others

Global Immunoglobulin Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

CSL Behring (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Grifols (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takeda Pharmaceutical Company Limited (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Octapharma AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kedrion Biopharma (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shire (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biotest AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
China Biologic Products Holdings, Inc. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanquin (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LFB Group (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio Products Laboratory (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ADMA Biologics, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GC Pharma (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bharat Serums and Vaccines Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shanghai RAAS Blood Products Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Grifols Biologicals Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BPL Plasma, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Green Cross Corporation (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Beijing Tiantan Biological Products Corporation Limited (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Emergent BioSolutions (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments